Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $39,508 | 9 | 94.9% |
| Travel and Lodging | $1,372 | 4 | 3.3% |
| Food and Beverage | $767.49 | 11 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $22,634 | 13 | $0 (2019) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $5,355 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $4,900 | 2 | $0 (2024) |
| Janssen Research & Development, LLC | $4,500 | 1 | $0 (2022) |
| Otsuka Pharmaceutical Co., Ltd. | $2,246 | 3 | $0 (2021) |
| SANOFI US SERVICES INC. | $1,823 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $189.12 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,674 | 5 | E.R. Squibb & Sons, L.L.C. ($4,900) |
| 2022 | $4,618 | 2 | Janssen Research & Development, LLC ($4,500) |
| 2021 | $4,475 | 2 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($2,475) |
| 2019 | $22,881 | 15 | GlaxoSmithKline, LLC. ($22,634) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 12/22/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $71.54 | General |
| 07/19/2024 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $1,822.50 | General |
| 06/17/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 01/25/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,880.00 | General |
| 09/04/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $117.58 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2022 | Janssen Research & Development, LLC | DARZALEX (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: Oncology | ||||||
| 05/26/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| 03/18/2021 | Otsuka Pharmaceutical Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 11/18/2019 | Otsuka Pharmaceutical Co., Ltd. | — | Travel and Lodging | In-kind items and services | $166.43 | General |
| 11/18/2019 | Otsuka Pharmaceutical Co., Ltd. | — | Food and Beverage | In-kind items and services | $79.85 | General |
| 08/20/2019 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $5,570.00 | General |
| 02/26/2019 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $15,360.16 | General |
| 02/20/2019 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $413.36 | General |
| 01/29/2019 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $533.62 | General |
| 01/29/2019 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $258.78 | General |
| 01/29/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $107.61 | General |
| 01/29/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $101.64 | General |
| 01/29/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $75.90 | General |
| 01/29/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $73.09 | General |
| 01/29/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $37.33 | General |
| 01/29/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $35.19 | General |
| 01/29/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $33.88 | General |
| 01/29/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $33.88 | General |
About Dr. Ignacio Sanz, MD
Dr. Ignacio Sanz, MD is a Rheumatology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780601872.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ignacio Sanz, MD has received a total of $41,647 in payments from pharmaceutical and medical device companies, with $9,674 received in 2024. These payments were reported across 24 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($39,508).
Practice Information
- Specialty Rheumatology
- Location Rochester, NY
- Active Since 07/16/2006
- Last Updated 10/30/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1780601872
Products in Payments
- DARZALEX (Drug) $4,500
- COSENTYX (Biological) $117.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Rochester
Dr. Delfin Santos, M.d, M.D
Rheumatology — Payments: $558,792
Cornelia Weyand, M.d, M.D
Rheumatology — Payments: $75,777
Eric Matteson, M.d, M.D
Rheumatology — Payments: $74,289
Kenneth Warrington, Md, MD
Rheumatology — Payments: $54,106
John Davis, M.d, M.D
Rheumatology — Payments: $34,273
Ashima Makol, M.d, M.D
Rheumatology — Payments: $17,025